AlTi Global Leads Our Selection Of 3 Promising Penny Stocks

Simply Wall St.07-21

Over the last 7 days, the United States market has dropped 1.4%, though it remains up 17% over the past year with earnings forecast to grow by 18% annually. Investing in penny stocks, a term that may ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2653822277?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","is_english":true,"pubTime":"2026-07-21 19:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653822277","market":"nz","top_or_hot":-1,"title":"AlTi Global Leads Our Selection Of 3 Promising Penny Stocks","media":"Simply Wall St.","content":"<div>\n<p>Over the last 7 days, the United States market has dropped 1.4%, though it remains up 17% over the past year with earnings forecast to grow by 18% annually. Investing in penny stocks, a term that may ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-cers/cerus/news/alti-global-leads-our-selection-of-3-promising-penny-stocks\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AlTi Global Leads Our Selection Of 3 Promising Penny Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlTi Global Leads Our Selection Of 3 Promising Penny Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-21 19:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-cers/cerus/news/alti-global-leads-our-selection-of-3-promising-penny-stocks><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the last 7 days, the United States market has dropped 1.4%, though it remains up 17% over the past year with earnings forecast to grow by 18% annually. Investing in penny stocks, a term that may ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-cers/cerus/news/alti-global-leads-our-selection-of-3-promising-penny-stocks\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-cers/cerus/news/alti-global-leads-our-selection-of-3-promising-penny-stocks","article_id":"2653822277","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-cers/cerus/news/alti-global-leads-our-selection-of-3-promising-penny-stocks","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2653822277","pubTimestamp":1784631906,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Over the last 7 days, the United States market has dropped 1.4%, though it remains up 17% over the past year with earnings forecast to grow by 18% annually. Investing in penny stocks, a term that may seem outdated but still holds relevance, can offer unique growth opportunities typically found in smaller or newer companies. By focusing on those with strong financial health and solid fundamentals, investors might uncover hidden gems that align well with current market conditions.","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","ALTI":"AlTi Global","CERS":"Cerus Corporation","BK4198":"医疗保健用品","ORMP":"Oramed Pharmaceuticals Inc","BK4135":"资产管理与托管银行"},"translate_title":"AlTi Global 引领我们精选了 3 只有前途的细价股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALTI":1.5,"ORMP":1,"CERS":1},"content_text":"Over the last 7 days, the United States market has dropped 1.4%, though it remains up 17% over the past year with earnings forecast to grow by 18% annually. Investing in penny stocks, a term that may seem outdated but still holds relevance, can offer unique growth opportunities typically found in smaller or newer companies. By focusing on those with strong financial health and solid fundamentals, investors might uncover hidden gems that align well with current market conditions.Let's dive into some prime choices out of the screener.AdvertisementAlTi Global (ALTI)Simply Wall St Financial Health Rating: ★★★★☆☆Overview: AlTi Global, Inc. is a company that offers wealth and asset management services across various international locations, with a market cap of $520.10 million.Operations: The company generates its revenue primarily from its Wealth & Capital Solutions segment, which accounts for $270.97 million.Market Cap: $520.1MAlTi Global, Inc., with a market cap of US$520.10 million, is experiencing financial challenges typical of penny stocks. The company's short-term assets exceed its short-term liabilities by US$10.1 million but fall short in covering long-term liabilities by US$51.6 million. Despite being unprofitable and having increased losses over the past five years, AlTi has sufficient cash runway for 1.7 years if free cash flow continues to decrease at historical rates. Recent developments include the appointment of Patrick Keenan as CFO and the deployment of Nevis AI platform to enhance operational efficiency in wealth management services.Jump into the full analysis health report here for a deeper understanding of AlTi Global.Evaluate AlTi Global's prospects by accessing our earnings growth report.ALTI Financial Position Analysis as at Jul 2026Oramed Pharmaceuticals (ORMP)Simply Wall St Financial Health Rating: ★★★★★★Overview: Oramed Pharmaceuticals Inc. focuses on the research and development of pharmaceutical solutions using a technology platform for oral delivery of therapeutic proteins, with a market cap of $164.93 million.Operations: Currently, Oramed Pharmaceuticals Inc. does not report any revenue segments.Market Cap: $164.93MOramed Pharmaceuticals Inc., with a market cap of US$164.93 million, is a pre-revenue company in the biotech sector, focusing on oral delivery technology for therapeutic proteins. Despite lacking significant revenue streams, Oramed has demonstrated strong financial health with short-term assets of US$68.2 million exceeding both short-term and long-term liabilities. The company recently achieved profitability, reporting net income of US$38.31 million for Q1 2026 compared to a loss last year. Oramed's addition to multiple Russell indices highlights its growing market presence, while its debt-free status and high return on equity (46.2%) underscore solid financial management.Click here to discover the nuances of Oramed Pharmaceuticals with our detailed analytical financial health report.Evaluate Oramed Pharmaceuticals' historical performance by accessing our past performance report.ORMP Financial Position Analysis as at Jul 2026Cerus (CERS)Simply Wall St Financial Health Rating: ★★★★★☆Overview: Cerus Corporation is a biomedical products company with a market cap of $627.15 million.Operations: The company's revenue is primarily derived from its Blood Safety segment, totaling $216.56 million.Market Cap: $627.15MCerus Corporation, with a market cap of US$627.15 million, has shown significant growth in its Blood Safety segment, generating US$216.56 million in revenue. Recent inclusion in the S&P Healthcare Equipment Select Industry Index and a new debt facility with MidCap Financial provide financial flexibility and reduced interest expenses by up to US$3.5 million annually. Despite being unprofitable, Cerus has reduced losses over five years at 28.2% annually and forecasts earnings growth of 94.61% per year. The company's short-term assets exceed liabilities, but an increased debt-to-equity ratio from 69.7% to 124.2% warrants caution for investors seeking stability in penny stocks.Get an in-depth perspective on Cerus' performance by reading our balance sheet health report here.Review our growth performance report to gain insights into Cerus' future.CERS Revenue & Expenses Breakdown as at Jul 2026Key TakeawaysDiscover the full array of 324  US Penny Stocks right here.Ready For A Different Approach? We've found 10 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.  This article by Simply Wall St is general in nature. We provide commentary based on historical data \n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your \n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data. \n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. \n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2653822277","isCrawlerRequest":true}